<div id="readability-page-1"><p>Wells Fargo analyst Brandon Couillard maintained a Buy rating on Guardant Health on May 9 and set a price target of $125.00.</p><h3>Claim 55% Off TipRanks</h3><ul><li>Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions  </li><li> Discover top-performing stock ideas and upgrade to a portfolio of market leaders with  Smart Investor Picks  </li></ul> <p>According to TipRanks, Couillard is a 5-star analyst with an average return of <span>15.6%</span> and a 58.51% success rate. Couillard covers the Healthcare sector, focusing on stocks such as Guardant Health, Bio-Rad Laboratories, and Myriad Genetics.</p> <p>In addition to Wells Fargo, Guardant Health also received a Buy from Guggenheim’s Subbu Nambi in a report issued yesterday. However, on May 8, Evercore ISI maintained a Hold rating on Guardant Health (NASDAQ: GH).</p></div>

IDNA

<p>Wells Fargo analyst Brandon Couillard has maintained a Buy rating on Guardant Health (GH) with a price target of $125.00. Couillard, a 5-star analyst, has an average return of 15.6% and a success rate of 58.51%. Guardant Health also received a Buy rating from Guggenheim’s Subbu Nambi, while Evercore ISI maintained a Hold rating on May 8.</p>

Tip Ranks

Guardant Health

Health Care Select Sector SPDR

iShares Genomics Immunology and Healthcare ETF

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

Invesco Biotechnology & Genome ETF

iShares Biotechnology ETF

iShares US Healthcare Providers

VanEck Biotech ETF

Direxion S&P Biotech Bull 3X

Ark Genomic Revolution ETF

iShares US Medical Devices

ALPS Medical Breakthrough

Wells Fargo

Bio-Rad Lab

Myriad Genetic

Evercore

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

Bio-Rad Lab-B

Guardant Health (GH) Gets a Buy from Wells Fargo